BioMarin anticipates $3.8B-$3.9B 2026 revenue while flagging $70M order deferrals
Read the full article on Seeking Alpha →
KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.
KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.